Use access key #2 to skip to page content.
$36.93 0.48 (1.32%)
5/12/2008 4:03 PM

sanofi-aventis (ADR) (SNY)

CAPS Rating:
*****

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating SNY

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

480 Outperforms
34 Underperforms
 

All-Stars

159 Outperforms
12 Underperforms
 

Wall Street

8 Outperforms
2 Underperforms
 

Players bullish on SNY are also bullish on:

Players bearish on SNY are also bearish on:

Ticker Tags

Multinational Company (16), Drug Manufacturers - Other (105), Mega Cap (146), Dividend (184), France (24), Buffett Stock (50), Behemoth (33), Bird Flu (8), Big Pharma (12)
Suggest a tag

sanofi-aventis (ADR) At A Glance

Current Price: $36.93
Last Trade Time: 5/12/2008 4:03 PM
Open: $36.44
Previous Close: $36.45
Daily Range: $36.44 - $37.07
52-Week Range: $35.06 - $49.04
Volume: 1,787,581
Market Cap: $99.58B
P/E Ratio: 19.60
Compare Our Special Broker Offers!

Stock Trends

SNY VS S&P 500 (SPY)

SNY 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

1

sanofi-aventis (ADR) (SNY)

Avatar Gtrinvestor (99.96) Submitted: 4/17/08 12:29 PM

It seems that all that matters to people any more is access to the best in health care. I'm guessing that this is only going to become more of an issue w/ the again US population, and the growing overseas wealth.





Everyone is betting against drug companies right now b/c so...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 95 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (SNY)

Avatar randnew (64.20) Submitted: 5/12/08 3:47 PM : Outperform Start Price: $36.96 SNY Score: -0.17

near lows, 5 stars

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SNY)

Avatar deuspecuniae (< 20) Submitted: 5/01/08 12:11 PM : Outperform Start Price: $38.77 SNY Score: -5.36

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SNY)

Avatar TMFBreakerBrian (97.78) Submitted: 4/30/08 10:26 AM : Underperform Start Price: $38.78 SNY Score: 5.52

Lovenox generics? Plavix issues? Lower share price? We'll see

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SNY)

Avatar Caps5StarLargeCa (99.31) Submitted: 4/27/08 10:22 AM : Outperform Start Price: $39.05 SNY Score: -5.89

5 stars on Caps
Market Cap > $20B

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (SNY)

Avatar Gtrinvestor (99.96) Submitted: 4/17/08 12:29 PM : Outperform Start Price: $38.01 SNY Score: -6.21

It seems that all that matters to people any more is access to the best in health care. I'm guessing that this is only going to become more of an issue w/ the again US population, and the growing overseas wealth.





Everyone is betting against drug companies right now b/c so many drugs are coming off patent, but tell me seriously, do you think that they aren't going to come up w/ something else in the future?

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 95 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 10 of 10  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackNWQ 29.20 09/30/07 Outperform NS $42.42-12.94%-7.94%-5.00 Toggle the visibility of 60-Second Pitch and replies
TrackBuffett 62.83 09/30/07 Outperform NS $42.42-12.94%-7.94%-5.00 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 86.50 09/30/07 Outperform NS $42.42-12.94%-7.94%-5.00 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 93.10 09/30/07 Outperform NS $42.42-12.94%-7.94%-5.00 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $42.42-12.94%-7.94%-5.00 Toggle the visibility of 60-Second Pitch and replies
TrackHSBC 93.94 07/18/07 Outperform NS $42.76-13.63%-8.93%-4.71
TrackJimCramer 81.00 03/21/07 Underperform 3W $42.59-13.29%-1.98%+11.32
TrackCharlesPayne 58.71 12/16/06 Outperform 3M $44.79-17.54%-1.32%-16.22
TrackBofASec 94.03 11/10/06 Outperform NS $41.39-10.78%+1.68%-12.45
TrackBearStearns 93.79 11/01/06 Underperform NS $41.82-11.69%+1.62%+13.31

Results 1 - 10 of 10  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners